SCHEMBL26288124

SCHEMBL26288124

CO[C@H]1C(O[Si](C)(C)C(C)(C)C)[C@@](CCl)(CO[Si](C)(C)C(C)(C)C)O[C@H]1n1ccc(N)nc1=O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.35
▸ THRB P10828 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ MDM2 Q00987 1/20 0.35
▸ NCOA1 Q15788 1/20 0.35
▸ NCOA3 Q9Y6Q9 1/20 0.35
▸ PDE3A Q14432 3/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ SLC29A1 Q99808 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ NT5E P21589 1/20 0.31
▸ CACNA1F O60840 2/20 0.31
▸ ALB P02768 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ CACNA1D Q01668 2/20 0.31
▸ CACNA1S Q13698 2/20 0.31
▸ CACNA1C Q13936 2/20 0.31
▸ TSHR P16473 1/20 0.31
▸ GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25401632 1.00 LMNA (0.35) LMNATHRBMTORMDM2NCOA1
SCHEMBL26274605 0.90 LMNA (0.36) LMNATHRBMTORMDM2NCOA1
SCHEMBL25402542 0.90 LMNA (0.36) LMNATHRBMTORMDM2NCOA1
SCHEMBL25401128 0.89 LMNA (0.35) LMNATHRBMTORMDM2NCOA1
SCHEMBL26273699 0.89 LMNA (0.35) LMNATHRBMTORMDM2NCOA1
SCHEMBL19861752 0.86 LMNA (0.36) LMNATHRBMTORMDM2NCOA1
SCHEMBL25400265 0.83 DUT (0.45) SLC29A1
SCHEMBL26288122 0.83 DUT (0.45) SLC29A1
SCHEMBL22068883 0.81 LMNA (0.32) LMNATHRBMTORMDM2NCOA1
SCHEMBL21124496 0.80 LMNA (0.41) LMNATHRBMTORMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023178133-A9 COMPOUNDS AND METHODS FOR TREATING DISEASE ROME THERAPEUTICS, INC. (US) 2023-10-26 — — WO disclosed
WO-2023178133-A1 COMPOUNDS AND METHODS FOR TREATING DISEASE ROME THERAPEUTICS, INC. (US) 2023-09-21 — — WO disclosed
Send feedback